• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α/β干扰素受体缺陷小鼠作为埃博拉病毒病的模型

Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease.

作者信息

Brannan Jennifer M, Froude Jeffery W, Prugar Laura I, Bakken Russell R, Zak Samantha E, Daye Sharon P, Wilhelmsen Catherine E, Dye John M

机构信息

US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland.

出版信息

J Infect Dis. 2015 Oct 1;212 Suppl 2:S282-94. doi: 10.1093/infdis/jiv215. Epub 2015 May 4.

DOI:10.1093/infdis/jiv215
PMID:25943199
Abstract

A major obstacle in ebolavirus research is the lack of a small-animal model for Sudan virus (SUDV), as well as other wild-type (WT) ebolaviruses. Here, we expand on research by Bray and by Lever et al suggesting that WT ebolaviruses are pathogenic in mice deficient for the type 1 interferon (IFN) α/β receptor (IFNα/βR-/-). We examined the disease course of several WT ebolaviruses: Boneface (SUDV/Bon) and Gulu variants of SUDV, Ebola virus (EBOV), Bundibugyo virus (BDBV), Taï Forest virus, and Reston virus (RESTV). We determined that exposure to WT SUDV or EBOV results in reproducible signs of disease in IFNα/βR-/- mice, as measured by weight loss and partial lethality. Vaccination with the SUDV or EBOV glycoprotein (GP)-expressing Venezuelan equine encephalitis viral replicon particle vaccine protected these mice from SUDV/Bon and EBOV challenge, respectively. Treatment with SUDV- or EBOV-specific anti-GP antibodies protected mice from challenge when delivered 1-3 days after infection. Serial sampling experiments revealed evidence of disseminated intravascular coagulation in the livers of mice infected with the Boneface variant of SUDV, EBOV, and BDBV. Taken together, these data solidify the IFNα/βR-/- mouse as an important and useful model for the study of WT EBOV disease.

摘要

埃博拉病毒研究中的一个主要障碍是缺乏针对苏丹病毒(SUDV)以及其他野生型(WT)埃博拉病毒的小动物模型。在此,我们拓展了布雷(Bray)以及利弗(Lever)等人的研究,他们提出野生型埃博拉病毒对缺乏1型干扰素(IFN)α/β受体(IFNα/βR -/-)的小鼠具有致病性。我们研究了几种野生型埃博拉病毒的病程:博内法斯(SUDV/Bon)和苏丹病毒的古卢变种、埃博拉病毒(EBOV)、本迪布焦病毒(BDBV)、塔伊森林病毒以及雷斯顿病毒(RESTV)。我们确定,通过体重减轻和部分致死率来衡量,暴露于野生型苏丹病毒或埃博拉病毒会在IFNα/βR -/-小鼠中引发可重现的疾病迹象。用表达苏丹病毒或埃博拉病毒糖蛋白(GP)的委内瑞拉马脑炎病毒复制子颗粒疫苗进行接种,分别保护这些小鼠免受博内法斯型苏丹病毒和埃博拉病毒的攻击。在感染后1至3天给予苏丹病毒或埃博拉病毒特异性抗GP抗体进行治疗,可保护小鼠免受攻击。连续采样实验揭示了感染博内法斯型苏丹病毒、埃博拉病毒和本迪布焦病毒的小鼠肝脏中存在弥散性血管内凝血的证据。综上所述,这些数据巩固了IFNα/βR -/-小鼠作为研究野生型埃博拉病毒病的重要且有用模型的地位。

相似文献

1
Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease.α/β干扰素受体缺陷小鼠作为埃博拉病毒病的模型
J Infect Dis. 2015 Oct 1;212 Suppl 2:S282-94. doi: 10.1093/infdis/jiv215. Epub 2015 May 4.
2
Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.基于痘病毒的埃博拉病毒表达 GP 和 VP40 蛋白疫苗候选物的免疫原性和疗效的差异。
J Virol. 2018 May 14;92(11). doi: 10.1128/JVI.00363-18. Print 2018 Jun 1.
3
Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.通过对转染色体牛进行DNA疫苗接种产生的人源多克隆抗体为小鼠提供暴露后针对致死性扎伊尔和苏丹埃博拉病毒的保护。
PLoS One. 2015 Sep 30;10(9):e0137786. doi: 10.1371/journal.pone.0137786. eCollection 2015.
4
Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.三价副流感病毒载体埃博拉病毒疫苗诱导的抗体介导的保护机制。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01845-18. Print 2019 Feb 15.
5
Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.委内瑞拉马脑炎病毒复制子颗粒疫苗可保护非人灵长类动物免受埃博拉病毒的肌肉内和呼吸道挑战。
J Virol. 2013 May;87(9):4952-64. doi: 10.1128/JVI.03361-12. Epub 2013 Feb 13.
6
Vaccination with recombinant adenoviruses expressing Ebola virus glycoprotein elicits protection in the interferon alpha/beta receptor knock-out mouse.用表达埃博拉病毒糖蛋白的重组腺病毒进行免疫接种可在干扰素 α/β 受体敲除小鼠中引起保护作用。
Virology. 2014 Mar;452-453:324-33. doi: 10.1016/j.virol.2013.03.028. Epub 2014 Jan 24.
7
Importin-α7 Is Involved in the Formation of Ebola Virus Inclusion Bodies but Is Not Essential for Pathogenicity in Mice.输入蛋白-α7参与埃博拉病毒包涵体的形成,但对小鼠致病性并非必需。
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S316-21. doi: 10.1093/infdis/jiv240. Epub 2015 Jul 16.
8
A Naturally Occurring Polymorphism in the Base of Sudan Virus Glycoprotein Decreases Glycoprotein Stability in a Species-Dependent Manner.苏丹病毒糖蛋白碱基中的自然发生多态性以物种依赖的方式降低糖蛋白稳定性。
J Virol. 2021 Aug 25;95(18):e0107321. doi: 10.1128/JVI.01073-21.
9
A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates.两株抗体泛埃博拉病毒鸡尾酒疗法在雪貂和非人灵长类动物中提供广泛的治疗保护。
Cell Host Microbe. 2019 Jan 9;25(1):49-58.e5. doi: 10.1016/j.chom.2018.12.005.
10
A Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates.一种库京复制子病毒样颗粒疫苗可保护非人灵长类动物免受埃博拉病毒感染。
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S368-71. doi: 10.1093/infdis/jiv019. Epub 2015 Mar 2.

引用本文的文献

1
Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus Infection.发现纳米抗体Nanosota-EB1和-EB2作为抗埃博拉病毒感染的新型纳米抗体抑制剂。
PLoS Pathog. 2024 Dec 23;20(12):e1012817. doi: 10.1371/journal.ppat.1012817. eCollection 2024 Dec.
2
Pathogenic differences of cynomolgus macaques after Taï Forest virus infection depend on the viral stock propagation.感染塞内加尔猕猴后,依病毒株繁殖方式而定的 Taï 森林病毒的致病性差异。
PLoS Pathog. 2024 Jun 11;20(6):e1012290. doi: 10.1371/journal.ppat.1012290. eCollection 2024 Jun.
3
Current Progress of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Vaccine Development.
严重发热伴血小板减少综合征病毒(SFTSV)疫苗研发的最新进展。
Viruses. 2024 Jan 16;16(1):128. doi: 10.3390/v16010128.
4
Animal models of mpox virus infection and disease.猴痘病毒感染与疾病的动物模型。
Infect Med (Beijing). 2023 Jun 4;2(3):153-166. doi: 10.1016/j.imj.2023.05.004. eCollection 2023 Sep.
5
Pathogenicity of Lloviu and Bombali Viruses in Type I Interferon Receptor Knockout Mice.Lloviu 和 Bombali 病毒在 I 型干扰素受体敲除小鼠中的致病性。
J Infect Dis. 2023 Nov 13;228(Suppl 7):S548-S553. doi: 10.1093/infdis/jiad226.
6
Animal Model Alternatives in Filovirus and Bornavirus Research.动物模型在丝状病毒和博尔纳病毒研究中的应用。
Viruses. 2023 Jan 4;15(1):158. doi: 10.3390/v15010158.
7
Mouse models of Ebola virus tolerance and lethality: characterization of CD-1 mice infected with wild-type, guinea pig-adapted, or mouse-adapted virus.埃博拉病毒耐受性和致死性的小鼠模型:感染野生型、豚鼠适应型或小鼠适应型病毒的CD-1小鼠的特征
Antiviral Res. 2023 Feb;210:105496. doi: 10.1016/j.antiviral.2022.105496. Epub 2022 Dec 22.
8
Macrophage infection, activation, and histopathological findings in ebolavirus infection.埃博拉病毒感染中的巨噬细胞感染、激活和组织病理学发现。
Front Cell Infect Microbiol. 2022 Oct 12;12:1023557. doi: 10.3389/fcimb.2022.1023557. eCollection 2022.
9
Natural history of infection in rhesus and cynomolgus macaques.恒河猴和食蟹猴感染的自然史。
Emerg Microbes Infect. 2022 Dec;11(1):1635-1646. doi: 10.1080/22221751.2022.2086072.
10
Comparison of Aerosol Stability of Different Variants of Ebola Virus and Marburg Virus and Virulence of Aerosolised Ebola Virus in an Immune-Deficient Mouse.不同变异型埃博拉病毒和马尔堡病毒的气溶胶稳定性比较及免疫缺陷小鼠中气溶胶化埃博拉病毒的毒力。
Viruses. 2022 Apr 9;14(4):780. doi: 10.3390/v14040780.